Spectral AI (MDAIW) Cash & Equivalents Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Spectral AI | - | - | 2.03 Mn | -17.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.11% |
| Dec 31, 2025 | 198.62% |
| Sep 30, 2025 | 183.63% |
| Jun 30, 2025 | 52.68% |
| Mar 31, 2025 | 38.44% |
| Dec 31, 2024 | 7.66% |
| Sep 30, 2024 | -49.62% |
| Jun 30, 2024 | 1,581.29% |
| Mar 31, 2024 | 1,774.54% |
| Dec 31, 2023 | -66.21% |
| Sep 30, 2023 | -49.70% |
| Jun 30, 2023 | 81.19% |
| Mar 31, 2023 | 16.30% |
| Dec 31, 2022 | -12.08% |
| Sep 30, 2022 | 1,591.07% |
| Jun 30, 2022 | -74.01% |
| Mar 31, 2022 | -71.27% |